Planned studies to evaluate immune checkpoint inhibitors in MMR deficient GI cancers Annual Meeting Gi 2016

David H. Ilson, MD of Memorial Sloan Kettering Cancer Center discusses planned studies to evaluate immune checkpoint inhibitors in MMR deficient GI cancers at ASCO Gi 2016